The Effectiveness of Long-Term Agalsidase Alfa Therapy in the Treatment of Fabry Nephropathy
Sandro Feriozzi, Joan Torras, Markus Cybulla, Kathy Nicholls, Gere Sunder-Plassmann, Michael West
Clinical Journal of the American Society of Nephrology | AMER SOC NEPHROLOGY | Published : 2012
S.F., J.T., MC., G.S.-P., and M.W. received speaker fees, travel grants, and research support from Shire HGT and Genzyme. K.N. received travel grants and research support from Shire HGT, Genzyme, and Amicus.Data collection and analysis in FOS were supported by Shire Human Genetic Therapies (HGT). Funding for editorial assistance was provided by Shire HGT.